All data are based on the daily closing price as of April 2, 2025
n

Nippon Shinyaku

4516.TSE
24.60 USD
-0.53
-2.11%

Overview

Last close
24.60 usd
Market cap
1.66B usd
52 week high
39.01 usd
52 week low
17.41 usd
Target price
28.15 usd

Valuation

P/E
8.2513
Forward P/E
12.9199
Price/Sales
1.5993
Price/Book Value
1.0352
Enterprise Value
1.33B usd
EV/Revenue
1.2659
EV/EBITDA
4.6984

Key financials

Revenue TTM
1.05B usd
Gross Profit TTM
711.19M usd
EBITDA TTM
263.44M usd
Earnings per Share
3.02 usd
Dividend
0.83 usd
Total assets
1.82B usd
Net debt
-338.88M usd

About

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases. The company's Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements. The company in the Strategic Partnership with Nippon Shinyaku will develop and commercialize for Mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
  • Symbol
    4516.TSE
  • Exchange
    TSE
  • Isin
    JP3717600005
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Kyoto
  • Web site
    https://www.nippon-shinyaku.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top